GELFOND RICHARD L 4

What Happened
Richard L. Gelfond, CEO of IMAX Corp (IMAX), exercised stock options and immediately sold the resulting shares under a 10b5-1 plan. On 2026-04-16 he converted 41,737 options into common shares at an exercise price of $31.40 (value of shares on exercise = $1,310,542) and sold those 41,737 shares in the open market at $37.05 for proceeds of $1,546,339. On 2026-04-17 he converted 34,182 options at $31.40 (value = $1,073,315) and sold those 34,182 shares at $37.06 for proceeds of $1,266,689. Total shares sold = 75,919 for total gross proceeds of approximately $2.81M.

Key Details

• Transaction dates & prices:
  • 2026-04-16: Converted 41,737 options at $31.40; sold 41,737 shares at $37.05.
  • 2026-04-17: Converted 34,182 options at $31.40; sold 34,182 shares at $37.06.
• Money involved: total proceeds ≈ $2,813,028; value on exercise (shares received) ≈ $2,383,857.
• Shares/holdings after these transactions (per filing): options outstanding 1,341,354; restricted share units 231,562; common shares 765,002.
• Notable footnotes: conversions were exercises of stock options pursuant to a 10b5-1 plan dated December 9, 2025. The options were originally issued in 2016 and expire June 7, 2026; vesting occurred in three 2016 installments.
• Filing timeliness: Form 4 was filed on 2026-04-20, within the required reporting period for the April 16–17 transactions.

Context
This was essentially a cashless exercise: options were converted into shares and the resulting shares were sold shortly thereafter under a pre-established 10b5-1 trading plan. Such transactions are commonly routine (e.g., to cover option exercise costs or diversify) and should not be taken alone as a signal of insider sentiment.